Live Breaking News & Updates on Endovascular Issues

Stay updated with breaking news from Endovascular issues. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,. ....

New York , United States , Eden Prairie , Gary Maharaj , Surmodics Inc , Abbott Vascular Inc , Quarter Fiscal , Recent Business , Endovascular Issues , Low Profile , Thrombectomy System , Medical Device , Vitro Diagnostics , Abbott Vascular , Call Today , Private Securities Litigation Reform Act , Endovascular Today , Pounce Arterial , Annual Report , Consolidated Statements , Months Ended December , Stockholder Equity , Cash Equivalents , Device Revenue , Fiscal Year Ending September , Distribution Agreement ,

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending Septemb. ....

New York , United States , Eden Prairie , Gary Maharaj , Abbott Vascular Inc , Surmodics Inc , Quarter Fiscal , Recent Business , Endovascular Issues , Low Profile , Thrombectomy System , Medical Device , Vitro Diagnostics , Abbott Vascular , Call Today , Private Securities Litigation Reform Act , Endovascular Today , Pounce Arterial , Annual Report , Consolidated Statements , Months Ended December , Cash Equivalents , Device Revenue ,

Surmodics : Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance - Form 8-K -November 08, 2023 at 07:03 am EST

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results;

Introduces Fiscal Year 2024 Financial Guidance

November 8, 2023 07:00 a.m. ET

. ....

United States , New York , Eden Prairie , Gary Maharaj , Jack Powell , Surmodics Inc , Surmodics Reports Fourth Quarter , Fiscal Year , Quarter Fiscal , Recent Business Highlights , Endovascular Issues , Vitro Diagnostics , Fourth Quarter Fiscal , Months Ended September , Medical Device , Year Ended September , Call Today , Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Stockholder Equity , Cash Equivalents , Three Months Ended September , Fiscal Year Ending September , Year Estimate ,

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

08.11.2023 - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2023, and introduced . ....

United States , New York , Eden Prairie , Gary Maharaj , Sundance Sirolimus , Surmodics Inc , Total Revenue , Recent Business , Endovascular Issues , Vitro Diagnostics , Quarter Fiscal , Medical Device , Call Today , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Months Ended September , Year Ended September , Stockholder Equity , Cash Equivalents , Three Months Ended September , Fiscal Year Ending September , Distribution Agreement , Surmodics Stock , Surmodics Chart , Urmodics Kurs ,

Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) #InVitroDiagnostic Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2022, and updated its financial outlook for its fis. ....

United States , Eden Prairie , Gary Maharaj , Abbott Vascular Inc , Surmodics Inc , Company Development , Drug Administration , Invitrodiagnostic Surmodics Inc , Company Sundance , International Symposium On Endovascular Therapy , Quarter Fiscal , Recent Business , Midcap Financial , Vascular Interventional Advances , Endovascular Issues , International Symposium , Endovascular Therapy , Medical Device , Vitro Diagnostics , Distribution Agreement , Abbott Vascular , Bridgewater Bank , Call Today , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements ,